239 related articles for article (PubMed ID: 19259069)
21. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Boztug K; Dewey RA; Klein C
Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
[TBL] [Abstract][Full Text] [Related]
22. WASP-WIP complex in the molecular pathogenesis of Wiskott-Aldrich syndrome.
Sasahara Y
Pediatr Int; 2016 Jan; 58(1):4-7. PubMed ID: 26331277
[TBL] [Abstract][Full Text] [Related]
23. Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapy.
Avedillo Díez I; Zychlinski D; Coci EG; Galla M; Modlich U; Dewey RA; Schwarzer A; Maetzig T; Mpofu N; Jaeckel E; Boztug K; Baum C; Klein C; Schambach A
Mol Pharm; 2011 Oct; 8(5):1525-37. PubMed ID: 21851067
[TBL] [Abstract][Full Text] [Related]
24. Lentiviral-mediated gene therapy restores B cell tolerance in Wiskott-Aldrich syndrome patients.
Pala F; Morbach H; Castiello MC; Schickel JN; Scaramuzza S; Chamberlain N; Cassani B; Glauzy S; Romberg N; Candotti F; Aiuti A; Bosticardo M; Villa A; Meffre E
J Clin Invest; 2015 Oct; 125(10):3941-51. PubMed ID: 26368308
[TBL] [Abstract][Full Text] [Related]
25. Development of lentiviral gene therapy for Wiskott Aldrich syndrome.
Galy A; Roncarolo MG; Thrasher AJ
Expert Opin Biol Ther; 2008 Feb; 8(2):181-90. PubMed ID: 18194074
[TBL] [Abstract][Full Text] [Related]
26. Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis.
Frecha C; Toscano MG; Costa C; Saez-Lara MJ; Cosset FL; Verhoeyen E; Martin F
Gene Ther; 2008 Jun; 15(12):930-41. PubMed ID: 18323794
[TBL] [Abstract][Full Text] [Related]
27. Wiskott-Aldrich syndrome.
Notarangelo LD; Miao CH; Ochs HD
Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
[TBL] [Abstract][Full Text] [Related]
28. WASP and the phenotypic range associated with deficiency.
Notarangelo LD; Notarangelo LD; Ochs HD
Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):485-90. PubMed ID: 16264326
[TBL] [Abstract][Full Text] [Related]
29. Clinical aspects and molecular analysis of Chinese patients with Wiskott-Aldrich syndrome in Taiwan.
Lee WI; Yang CY; Jaing TH; Huang JL; Chien YH; Chang KW
Int Arch Allergy Immunol; 2008; 145(1):15-23. PubMed ID: 17703096
[TBL] [Abstract][Full Text] [Related]
30. Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome.
Rai R; Romito M; Rivers E; Turchiano G; Blattner G; Vetharoy W; Ladon D; Andrieux G; Zhang F; Zinicola M; Leon-Rico D; Santilli G; Thrasher AJ; Cavazza A
Nat Commun; 2020 Aug; 11(1):4034. PubMed ID: 32788576
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Labrosse R; Chu JI; Armant MA; Everett JK; Pellin D; Kareddy N; Frelinger AL; Henderson LA; O'Connell AE; Biswas A; Coenen-van der Spek J; Miggelbrink A; Fiorini C; Adhikari H; Berry CC; Cantu VA; Fong J; Jaroslavsky J; Karadeniz DF; Li QZ; Reddy S; Roche AM; Zhu C; Whangbo JS; Dansereau C; Mackinnon B; Morris E; Koo SM; London WB; Baris S; Ozen A; Karakoc-Aydiner E; Despotovic JM; Forbes Satter LR; Saitoh A; Aizawa Y; King A; Nguyen MAT; Vu VDU; Snapper SB; Galy A; Notarangelo LD; Bushman FD; Williams DA; Pai SY
Blood; 2023 Oct; 142(15):1281-1296. PubMed ID: 37478401
[TBL] [Abstract][Full Text] [Related]
32. Gene therapy for Wiskott-Aldrich Syndrome.
Bosticardo M; Ferrua F; Cavazzana M; Aiuti A
Curr Gene Ther; 2014; 14(6):413-21. PubMed ID: 25245089
[TBL] [Abstract][Full Text] [Related]
33. Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich syndrome gene.
Leuci V; Gammaitoni L; Capellero S; Sangiolo D; Mesuraca M; Bond HM; Migliardi G; Cammarata C; Aglietta M; Morrone G; Piacibello W
Stem Cells; 2009 Nov; 27(11):2815-23. PubMed ID: 19785032
[TBL] [Abstract][Full Text] [Related]
34. A possible turning point in the hematopoietic stem cell gene therapy for primary immunodeficiency diseases? Lentiviral vectors could take the place of retroviral vectors.
Ariga T
Expert Rev Clin Immunol; 2013 Nov; 9(11):1015-8. PubMed ID: 24168409
[TBL] [Abstract][Full Text] [Related]
35. Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation.
Sereni L; Castiello MC; Marangoni F; Anselmo A; di Silvestre D; Motta S; Draghici E; Mantero S; Thrasher AJ; Giliani S; Aiuti A; Mauri P; Notarangelo LD; Bosticardo M; Villa A
J Allergy Clin Immunol; 2018 Oct; 142(4):1272-1284. PubMed ID: 29421274
[TBL] [Abstract][Full Text] [Related]
36. Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs.
Trifari S; Scaramuzza S; Catucci M; Ponzoni M; Mollica L; Chiesa R; Cattaneo F; Lafouresse F; Calvez R; Vermi W; Medicina D; Castiello MC; Marangoni F; Bosticardo M; Doglioni C; Caniglia M; Aiuti A; Villa A; Roncarolo MG; Dupré L
J Allergy Clin Immunol; 2010 Feb; 125(2):439-448.e8. PubMed ID: 20159256
[TBL] [Abstract][Full Text] [Related]
37. The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function.
Blundell MP; Worth A; Bouma G; Thrasher AJ
Dis Markers; 2010; 29(3-4):157-75. PubMed ID: 21178275
[TBL] [Abstract][Full Text] [Related]
38. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.
Ochs HD
Immunol Res; 2009; 44(1-3):84-8. PubMed ID: 19082760
[TBL] [Abstract][Full Text] [Related]
39. Preclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndrome.
Scaramuzza S; Biasco L; Ripamonti A; Castiello MC; Loperfido M; Draghici E; Hernandez RJ; Benedicenti F; Radrizzani M; Salomoni M; Ranzani M; Bartholomae CC; Vicenzi E; Finocchi A; Bredius R; Bosticardo M; Schmidt M; von Kalle C; Montini E; Biffi A; Roncarolo MG; Naldini L; Villa A; Aiuti A
Mol Ther; 2013 Jan; 21(1):175-84. PubMed ID: 22371846
[TBL] [Abstract][Full Text] [Related]
40. Studies of the expression of the Wiskott-Aldrich syndrome protein.
Stewart DM; Treiber-Held S; Kurman CC; Facchetti F; Notarangelo LD; Nelson DL
J Clin Invest; 1996 Jun; 97(11):2627-34. PubMed ID: 8647957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]